title: Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4.
abstract: Beta1- and beta2-adrenergic receptors (betaARs) are highly homologous, yet they play clearly distinct roles in cardiac physiology and pathology. Myocyte contraction, for instance, is readily stimulated by beta1AR but not beta2AR signaling, and chronic stimulation of the two receptors has opposing effects on myocyte apoptosis and cell survival. Differences in the assembly of macromolecular signaling complexes may explain the distinct biological outcomes. Here, we demonstrate that beta1AR forms a signaling complex with a cAMP-specific phosphodiesterase (PDE) in a manner inherently different from a beta2AR/beta-arrestin/PDE complex reported previously. The beta1AR binds a PDE variant, PDE4D8, in a direct manner, and occupancy of the receptor by an agonist causes dissociation of this complex. Conversely, agonist binding to the beta2AR is a prerequisite for the recruitment of a complex consisting of beta-arrestin and the PDE4D variant, PDE4D5, to the receptor. We propose that the distinct modes of interaction with PDEs result in divergent cAMP signals in the vicinity of the two receptors, thus, providing an additional layer of complexity to enforce the specificity of beta1- and beta2-adrenoceptor signaling.
authors.affiliation: Division of Reproductive Biology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305-5317, USA.
authors.forename: Wito
authors.initials: W
authors.lastname: Richter
authors.forename: Peter
authors.initials: P
authors.lastname: Day
authors.forename: Rani
authors.initials: R
authors.lastname: Agrawal
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Bruss
authors.forename: Sébastien
authors.initials: S
authors.lastname: Granier
authors.forename: Yvonne L
authors.initials: YL
authors.lastname: Wang
authors.forename: Søren G F
authors.initials: SG
authors.lastname: Rasmussen
authors.forename: Kathleen
authors.initials: K
authors.lastname: Horner
authors.forename: Ping
authors.initials: P
authors.lastname: Wang
authors.forename: Tao
authors.initials: T
authors.lastname: Lei
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Patterson
authors.forename: Brian
authors.initials: B
authors.lastname: Kobilka
authors.forename: Marco
authors.initials: M
authors.lastname: Conti
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D002460:Cell Line; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4 / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D047468:Immunoprecipitation; D051379:Mice; D008954:Models, Biological; D032342:Muscle Cells / Q000166:cytology / Q000378:metabolism; D011401:Promoter Regions, Genetic / Q000235:genetics; D011485:Protein Binding; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D018342:Receptors, Adrenergic, beta-1 / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D018343:Receptors, Adrenergic, beta-2 / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D015398:Signal Transduction
chemical_list: D020033:Protein Isoforms; D018342:Receptors, Adrenergic, beta-1; D018343:Receptors, Adrenergic, beta-2; D000242:Cyclic AMP; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4